138 related articles for article (PubMed ID: 1894471)
1. The significance of complement in proliferative vitreoretinopathy.
Grisanti S; Wiedemann P; Weller M; Heimann K; Zilles K
Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2711-7. PubMed ID: 1894471
[TBL] [Abstract][Full Text] [Related]
2. [Proliferative vitreoretinopathy. Activation of the complement system].
Grisanti S; Esser P; Weller M; Wiedemann P; Heimann K
Ophthalmologe; 1992 Feb; 89(1):50-4. PubMed ID: 1533804
[TBL] [Abstract][Full Text] [Related]
3. Complement components in Nigerians with bronchial asthma.
Onyemelukwe GC
Ann Allergy; 1989 Oct; 63(4):309-12. PubMed ID: 2802267
[TBL] [Abstract][Full Text] [Related]
4. [Proliferative vitreoretinopathy. On the significance of protein transfer through the blood-retina barrier].
Grisanti S; Wiedemann P; Heimann K
Ophthalmologe; 1993 Oct; 90(5):468-71. PubMed ID: 8219633
[TBL] [Abstract][Full Text] [Related]
5. Levels of some complement components in azoospermic, oligospermic and normospermic Nigerian men.
Oyeyinka GO; Bello CS; Elegba OY; Nsofor BI
J Reprod Med; 1987 Oct; 32(10):774-6. PubMed ID: 3500310
[TBL] [Abstract][Full Text] [Related]
6. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin G, complement factor C3 and lymphocytes in proliferative intraocular disorders.
Weller M; Clausen R; Bresgen M; Heimann K; Wiedemann P
Int Ophthalmol; 1990 Jul; 14(4):277-83. PubMed ID: 2196238
[TBL] [Abstract][Full Text] [Related]
8. Complement and complement regulatory proteins in human tears.
Willcox MD; Morris CA; Thakur A; Sack RA; Wickson J; Boey W
Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):1-8. PubMed ID: 9008624
[TBL] [Abstract][Full Text] [Related]
9. Intercellular adhesion molecule-1 levels in plasma and vitreous from patients with vitreoretinal disorders.
Esser P; Bresgen M; Fischbach R; Heimann K; Wiedemann P
Ger J Ophthalmol; 1995 Sep; 4(5):269-74. PubMed ID: 7496336
[TBL] [Abstract][Full Text] [Related]
10. [A preliminary study on cytokines in proliferative vitreoretinopathy].
Li X; Huang J
Zhonghua Yan Ke Za Zhi; 1998 Jul; 34(4):256-9, 18. PubMed ID: 11877201
[TBL] [Abstract][Full Text] [Related]
11. Complement activation in fetuses: assessment by the levels of complement components and split products in cord blood.
Miyano A; Nakayama M; Fujita T; Kitajima H; Imai S; Shimizu A
Diagn Clin Immunol; 1987; 5(2):86-90. PubMed ID: 3497734
[TBL] [Abstract][Full Text] [Related]
12. [Quantitative determination of 5 vitreal proteins in the normal vitreous body and proliferative retinal diseases].
Clausen R; Weller M; Hilgers RD; Heimann K; Wiedemann P
Fortschr Ophthalmol; 1990; 87(3):283-6. PubMed ID: 2376377
[TBL] [Abstract][Full Text] [Related]
13. Studies on the haemolytic activity of circulating C1q-C3/C4 complexes.
Wouters D; Brouwer MC; Daha MR; Hack CE
Mol Immunol; 2008 Apr; 45(7):1893-9. PubMed ID: 18054386
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of RAGE and its ligands in proliferative retinal disease.
Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
[TBL] [Abstract][Full Text] [Related]
15. Vitreous proteomic analysis of proliferative vitreoretinopathy.
Yu J; Liu F; Cui SJ; Liu Y; Song ZY; Cao H; Chen FE; Wang WJ; Sun T; Wang F
Proteomics; 2008 Sep; 8(17):3667-78. PubMed ID: 18752205
[TBL] [Abstract][Full Text] [Related]
16. [Non-ionic iodinated dimeric versus monomeric X-ray contrast media: effects on complement factors in vivo].
Böhm I; Speck U; Schild H
Rofo; 2006 Mar; 178(3):306-12. PubMed ID: 16508838
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin binds C1q and activates the classical pathway of complement.
Peake PW; Shen Y; Walther A; Charlesworth JA
Biochem Biophys Res Commun; 2008 Mar; 367(3):560-5. PubMed ID: 18179772
[TBL] [Abstract][Full Text] [Related]
18. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
[No Abstract] [Full Text] [Related]
19. Complement activation and C1q binding activity in haemodialysis.
Dodd NJ; Vergani D; Turney JH; Parsons V; Weston MJ
Proc Eur Dial Transplant Assoc; 1981; 18():300-4. PubMed ID: 6977138
[No Abstract] [Full Text] [Related]
20. Changes of serum complement concentrations in tumour patients prior and after radiotherapy.
Beyer-Enke SA; Strauss LG; Georgi M
Strahlenther Onkol; 1986 Jul; 162(7):441-7. PubMed ID: 3488595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
